New data from Ascend’s R&D team demonstrate up to 3-fold increase in AAV yields, supporting greater efficiency and scalability across gene therapy programs. MUNICH, Nov. 10, 2025 /PRNewswire/ — Ascend Advanced Therapies today makes public data demonstrating the performance of two…
